- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Plaque psoriasis
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 1012KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 74KB)
Apremilast – July 2020
Apremilast: Tablet 30 mg, Pack containing 4 tablets of 10 mg, 4 tablets of 20 mg and 19 tablets of 30 mg; Otezla®
Last updated
30 October 2020